Menarini Asia-Pacific
Menarini is the world’s largest Italian biopharmaceutical company with a heritage of over 128 years, and more than 16,000 employees in over 100 countries. Here in Asia-Pacific, Menarini’s vision is to be a leading provider of important healthcare brands to improve the lives of people in the region.
See below for the Latest Menarini Asia-Pacific News, Analysis, Profit Results, Share Price Information, and Commentary.
How Menarini Asia Pacific achieves organisational excellence, harnesses agile go-to market approaches
How Menarini Asia Pacific achieves organisational excellence, harnesses agile go-to market approaches
CEO Maurizio Luongo highlights the expansion of the company’s omni-channel distribution strategy beyond traditional pharmaceuticals channels.
Menarini Asia-Pacific bags two awards at the SBR Management Excellence Awards 2022
It was recognised for having a robust team and an outstanding leader that guided the company to success.
Read Here
Advertise
Sign Up
Commentary
The future of cross-border commerce isn’t faster shipping – it’s better discovery
Delaying AI investment could become construction's most expensive decision
Can Johor-Singapore SEZ build ASEAN’s shared AI manufacturing ecosystem?
Machine-speed AI mistakes are Singapore’s next governance test
Banks need to rethink identity governance for AI agents
As Singapore broadens retail investing, who moves before the news?
Can controlled sandboxes prepare Singapore organisations for production AI?
What the latest sanctions regimes mean for Singapore businesses
Singapore’s tourism economy depends on security infrastructure most never see
Where does value creation really happen?